- Stealth BioTherapeutics Corp (NASDAQ:MITO) will be acquired by a consortium of investors led by Morningside Venture (I) Investments Ltd and J. Wood Capital Advisors LLC in an all-cash transaction.
- Each Stealth Bio will be canceled and cease to exist for the right to receive $0.03125 in cash. Each American Depositary Share representing 12 shares will be canceled for the right to receive $0.375.
- Related: Stealth Bio Shares Trading Higher On Pre-Clinical Presentation Of Neuromuscular Disease Candidate.
- The merger consideration represents a premium of 34.4% to the closing price on June 24, the last trading day before the company announced its receipt of the original “going-private” proposal.
- The merger is expected to close during the second half of 2022.
- Price Action: MITO shares are up 19.6% at $0.29 during the market session on the last check Monday.
What’s Going On With Chinese EV Stocks Nio And XPeng?
Nio and XPeng shares are trading higher Tuesday amid strength in Chinese EV stocks that may be impacted by the U.S. Treasury Secretary Janet Yellen's China trip and upcoming inflation data. Treasury Secretary Janet Yellen met with government officials in China to discuss trade policies and industrial practices. Yellen reported that initial talks were productive and both parties agreed to ongoing, intensive discussions on the matter.